125 related articles for article (PubMed ID: 35691500)
1. CCL21 and beta-cell antigen releasing hydrogels as tolerance-inducing therapy in Type I diabetes.
Zisi Tegou F; Velluto D; Stock AA; Fitzgerald SN; Stealey S; Zustiak SP; Bayer AL; Tomei AA
J Control Release; 2022 Aug; 348():499-517. PubMed ID: 35691500
[TBL] [Abstract][Full Text] [Related]
2. CCL21 Expression in β-Cells Induces Antigen-Expressing Stromal Cell Networks in the Pancreas and Prevents Autoimmune Diabetes in Mice.
Gonzalez Badillo FE; Zisi Tegou F; Abreu MM; Masina R; Sha D; Najjar M; Wright SH; Bayer AL; Korpos É; Pugliese A; Molano RD; Tomei AA
Diabetes; 2019 Oct; 68(10):1990-2003. PubMed ID: 31371518
[TBL] [Abstract][Full Text] [Related]
3. Tissue-Engineered Stromal Reticula to Study Lymph Node Fibroblastic Reticular Cells in Type I Diabetes.
Gonzalez Badillo F; Zisi Tegou F; Masina R; Wright S; Scully M; Harwell L; Lupp M; Postigo-Fernandez J; Creusot RJ; Tomei AA
Cell Mol Bioeng; 2020 Oct; 13(5):419-434. PubMed ID: 33184575
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic alterations in pancreatic lymph node stromal cells from human donors with type 1 diabetes and NOD mice.
Postigo-Fernandez J; Farber DL; Creusot RJ
Diabetologia; 2019 Nov; 62(11):2040-2051. PubMed ID: 31486854
[TBL] [Abstract][Full Text] [Related]
5. Infusion of UVB-treated splenic stromal cells induces suppression of beta cell antigen-specific T cell responses in NOD mice.
Xia CQ; Qiu Y; Peng RH; Lo-Dauer J; Clare-Salzler MJ
J Autoimmun; 2008 Jun; 30(4):283-92. PubMed ID: 18226498
[TBL] [Abstract][Full Text] [Related]
6. Auto-antigen and Immunomodulatory Agent-Based Approaches for Antigen-Specific Tolerance in NOD Mice.
Bassin EJ; Piganelli JD; Little SR
Curr Diab Rep; 2021 Feb; 21(3):9. PubMed ID: 33547977
[TBL] [Abstract][Full Text] [Related]
7. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis.
Luther SA; Bidgol A; Hargreaves DC; Schmidt A; Xu Y; Paniyadi J; Matloubian M; Cyster JG
J Immunol; 2002 Jul; 169(1):424-33. PubMed ID: 12077273
[TBL] [Abstract][Full Text] [Related]
8. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic non-beta cells suppress beta cell antigen-reactive T cells and induce beta cell antigen-specific regulatory T cells.
Xia CQ; Qiu Y; Peng R; Lo-Dauer J; Clare-Salzler MJ
Ann N Y Acad Sci; 2008 Dec; 1150():167-70. PubMed ID: 19120288
[TBL] [Abstract][Full Text] [Related]
10. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
Qu P; Ji RC; Shimoda H; Miura M; Kato S
Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
[TBL] [Abstract][Full Text] [Related]
11. CD4+ CD25+ regulatory T cells prevent type 1 diabetes preceded by dendritic cell-dominant invasive insulitis by affecting chemotaxis and local invasiveness of dendritic cells.
Lee MH; Lee WH; Todorov I; Liu CP
J Immunol; 2010 Aug; 185(4):2493-501. PubMed ID: 20639483
[TBL] [Abstract][Full Text] [Related]
12. Elevated IFN-alpha/beta levels in a streptozotocin-induced type I diabetic mouse model promote oxidative stress and mediate depletion of spleen-homing CD8+ T cells by apoptosis through impaired CCL21/CCR7 axis and IL-7/CD127 signaling.
Mahmoud MH; Badr G; Badr BM; Kassem AU; Mohamed MS
Cell Signal; 2015 Oct; 27(10):2110-9. PubMed ID: 26192098
[TBL] [Abstract][Full Text] [Related]
13. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY
Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715
[TBL] [Abstract][Full Text] [Related]
14. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
15. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes.
Zhang L; Sosinowski T; Cox AR; Cepeda JR; Sekhar NS; Hartig SM; Miao D; Yu L; Pietropaolo M; Davidson HW
J Autoimmun; 2019 Jan; 96():50-58. PubMed ID: 30122420
[TBL] [Abstract][Full Text] [Related]
16. Expression of CCL21 and 5'-Nase on pancreatic lymphatics in nonobese diabetic mice.
Qu P; Ji RC; Kato S
Pancreas; 2005 Aug; 31(2):148-55. PubMed ID: 16025002
[TBL] [Abstract][Full Text] [Related]
17. Multicomponent Injectable Hydrogels for Antigen-Specific Tolerogenic Immune Modulation.
Verbeke CS; Gordo S; Schubert DA; Lewin SA; Desai RM; Dobbins J; Wucherpfennig KW; Mooney DJ
Adv Healthc Mater; 2017 Mar; 6(6):. PubMed ID: 28116870
[TBL] [Abstract][Full Text] [Related]
18. Tolerogenic vaccination reduced effector memory CD4 T cells and induced effector memory Treg cells for type I diabetes treatment.
Zhang J; Gao W; Yang X; Kang J; Zhang Y; Guo Q; Hu Y; Xia G; Kang Y
PLoS One; 2013; 8(7):e70056. PubMed ID: 23894591
[TBL] [Abstract][Full Text] [Related]
19. Evidence for an enhanced adhesion of DC to fibronectin and a role of CCL19 and CCL21 in the accumulation of DC around the pre-diabetic islets in NOD mice.
Bouma G; Coppens JM; Mourits S; Nikolic T; Sozzani S; Drexhage HA; Versnel MA
Eur J Immunol; 2005 Aug; 35(8):2386-96. PubMed ID: 16047341
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation by subcutaneously injected methacrylic acid-based hydrogels and tolerogenic dendritic cells in a mouse model of autoimmune diabetes.
Kinney SM; Ortaleza K; Won SY; Licht BJM; Sefton MV
Biomaterials; 2023 Oct; 301():122265. PubMed ID: 37586232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
